MAYWOOD, Ill. - There has been an "explosion of new and innovative" therapies for neurologic conditions such as stroke, epilepsy, Parkinson’s disease and multiple sclerosis, Loyola University Medical Center neurologist Dr. Jose Biller writes in the August issue of the journal Neurologic Clinics.
Biller is editor of the August issue, which includes 14 articles describing the latest data on new and emerging therapies for neurologic conditions. Five of the articles are written by Loyola physicians:
Sarkis Morales Vidal, MD, and Sean Ruland, DO: "Platelet Antiaggregants in Stroke Prevention."
Adriana Sofia Ploneda Perilla and Michael J. Schneck, MD: "Unanswered Questions in Thrombolytic Therapy for Acute Ischemic Stroke."
Michael Star, MD, and Murray Flaster, MD, PhD: "Advances and Controversies in the Management of Cerebral Venous Thrombosis."
Jorge J. Asconape: "Epilepsy."
Douglas Anderson, MD, and Ninith Kartha, MD: "Deep Brain Stimulation in Nonparkinsonian Movement Disorders and Emerging Technologies, Targets and Therapeutic Promises in Deep Brain Stimulation."
Matthew McCoyd, MD: "Update on Therapeutic Options for Multiple Sclerosis."
In the preface, Biller writes that the August issue of Neurologic Clinics is intended to provide timely and practical information to physicians treating neurologic disorders. He concludes: "There is every reason to believe that future advances in neurologic therapy are sure to come."
Biller is chair of the Department of Neurology of Loyola University Chicago Stritch School of Medicine.